Itaconate utilisation by the human pathogen Pseudomonas aeruginosa requires uptake via the IctPQM TRAP transporter
Biochemical Journal · 2025
DOI: 10.1042/bcj20253132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2025. Verfasst von Javeria Mehboob und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of York, Wentworth Way, York, YO10 5DD, U.K. Hauptthemen laut MEDLINE: Succinates, Pseudomonas aeruginosa, Bacterial Proteins, Membrane Transport Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pseudomonas aeruginosa PA01 is one of the major causes of disease persistence and mortality in patients with lung pathologies, relying on various host metabolites as carbon and energy sources for growth. The ict-ich-ccl operon (pa0878, pa0882 and pa0883) in PAO1 is required for growth on the host molecule itaconate, a C5-dicarboxylate. However, it is not known how itaconate is taken up into P. aeruginosa. Here, we demonstrate that a genetically linked tripartite ATP-independent periplasmic (TRAP) transporter (pa0884-pa0886), which is homologous to the known C4-dicarboxylate-binding TRAP system, is essential for growth on itaconate, but not for the closely related C4-dicarboxylate succinate. Using tryptophan fluorescence spectroscopy, we demonstrate that the substrate-binding protein (SBP), IctP (PA0884), binds itaconate but still retains higher affinity for the related C4-dicarboxylates. The structures of IctP bound to itaconate (1.80 Å) and succinate (1.75 Å) revealed an enclosed ligand-binding pocket with ion pairing interactions with the ligand carboxylates. The C2 methylene group that is the distinguishing feature of itaconate compared with succinate is accommodated by a unique change in the IctP-binding site from a Leu to Val, which distinguishes it from closely related C4-dicarboxylate-binding SBPs. Together, these data suggest that this transporter, which we name IctPQM, has duplicated from a canonical C4-dicarboxylate transporter, and its evolution towards itaconate specificity enables this pathogen to now access a key metabolite for persistence in the host.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of York, Wentworth Way, York, YO10 5DD, U.K.
- York Biomedical Research Institute, University of York, YO10 5DD, U.K.
- Hull York Medical School, University of Hull, Hull, HU6 7RX, U.K.
- York Structural Biology Laboratory, Department of Chemistry, University of York, York, YO10 5DD, U.K.
ORCID-Profile: Javeria Mehboob, Reyme Herman, Rory C Elston, Bethan E Kinniment-Williams, Marjan W van der Woude, Anthony J Wilkinson, Gavin H Thomas
Zitieren
APA
Mehboob, J., Herman, R., Elston, R. C., Afolabi, H., Kinniment-Williams, B. E., van der Woude, M. W., Wilkinson, A. J., & Thomas, G. H. (2025). Itaconate utilisation by the human pathogen Pseudomonas aeruginosa requires uptake via the IctPQM TRAP transporter. Biochemical Journal. https://doi.org/10.1042/bcj20253132
Vancouver
Mehboob J, Herman R, Elston RC, Afolabi H, Kinniment-Williams BE, van der Woude MW, et al. Itaconate utilisation by the human pathogen Pseudomonas aeruginosa requires uptake via the IctPQM TRAP transporter. Biochemical Journal. 2025. doi:10.1042/bcj20253132
BibTeX
@article{Mehboob2025,
author = {Mehboob, Javeria and Herman, Reyme and Elston, Rory C and Afolabi, Heritage and Kinniment-Williams, Bethan E and van der Woude, Marjan W and Wilkinson, Anthony J and Thomas, Gavin H},
title = {Itaconate utilisation by the human pathogen Pseudomonas aeruginosa requires uptake via the IctPQM TRAP transporter},
journal = {Biochemical Journal},
year = {2025},
doi = {10.1042/bcj20253132}
}
EUVIMED